These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25352204)

  • 1. Mission critical: mobilization of essential animal models for Ebola, Nipah, and Machupo virus infections.
    Zumbrun EE
    Vet Pathol; 2015 Jan; 52(1):18-20. PubMed ID: 25352204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells.
    Hoffmann M; Nehlmeier I; Brinkmann C; Krähling V; Behner L; Moldenhauer AS; Krüger N; Nehls J; Schindler M; Hoenen T; Maisner A; Becker S; Pöhlmann S
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced surveillance and response approaches for pilgrims and local Saudi populations against emerging Nipah, Zika and Ebola viral diseases outbreaks threats.
    Tambo E; El-Dessouky AG; Khater EIM; Xianonng Z
    J Infect Public Health; 2020 May; 13(5):674-678. PubMed ID: 32265162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of Ebola virus infections in domestic animals.
    Weingartl HM; Nfon C; Kobinger G
    Dev Biol (Basel); 2013; 135():211-8. PubMed ID: 23689899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ebola virus circulation in Africa: a balance between clinical expression and epidemiological silence.
    Gonzalez JP; Herbreteau V; Morvan J; Leroy EM
    Bull Soc Pathol Exot; 2005 Sep; 98(3):210-7. PubMed ID: 16267963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of experimental and early investigational drugs for the treatment of Ebola virus infections.
    Wong G; Qiu X
    Expert Opin Investig Drugs; 2015; 24(8):999-1011. PubMed ID: 26065319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental Respiratory Infection of Marmosets (Callithrix jacchus) With Ebola Virus Kikwit.
    Smither SJ; Nelson M; Eastaugh L; Nunez A; Salguero FJ; Lever MS
    J Infect Dis; 2015 Oct; 212 Suppl 2():S336-45. PubMed ID: 26209682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system.
    Lee N; Shum D; König A; Kim H; Heo J; Min S; Lee J; Ko Y; Choi I; Lee H; Radu C; Hoenen T; Min JY; Windisch MP
    Antiviral Res; 2018 Oct; 158():226-237. PubMed ID: 30149038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of Ebola Therapeutics During the 2014-2015 Outbreak.
    Mendoza EJ; Qiu X; Kobinger GP
    Trends Mol Med; 2016 Feb; 22(2):164-173. PubMed ID: 26774636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
    Oestereich L; Lüdtke A; Wurr S; Rieger T; Muñoz-Fontela C; Günther S
    Antiviral Res; 2014 May; 105():17-21. PubMed ID: 24583123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection.
    Johansen LM; Brannan JM; Delos SE; Shoemaker CJ; Stossel A; Lear C; Hoffstrom BG; Dewald LE; Schornberg KL; Scully C; Lehár J; Hensley LE; White JM; Olinger GG
    Sci Transl Med; 2013 Jun; 5(190):190ra79. PubMed ID: 23785035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ebola virus: unravelling pathogenesis to combat a deadly disease.
    Hoenen T; Groseth A; Falzarano D; Feldmann H
    Trends Mol Med; 2006 May; 12(5):206-15. PubMed ID: 16616875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions.
    Geisbert TW; Hensley LE
    Expert Rev Mol Med; 2004 Sep; 6(20):1-24. PubMed ID: 15383160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models for ebolavirus countermeasures discovery: what defines a useful model?
    Shurtleff AC; Bavari S
    Expert Opin Drug Discov; 2015 Jul; 10(7):685-702. PubMed ID: 26004783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemics and Peptide Vaccine Response: A Brief Review.
    Nandy A; Dey S; Roy P; Basak SC
    Curr Top Med Chem; 2018; 18(26):2202-2208. PubMed ID: 30417788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single phosphorodiamidate morpholino oligomer targeting VP24 protects rhesus monkeys against lethal Ebola virus infection.
    Warren TK; Whitehouse CA; Wells J; Welch L; Heald AE; Charleston JS; Sazani P; Reid SP; Iversen PL; Bavari S
    mBio; 2015 Feb; 6(1):. PubMed ID: 25670780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing preparation for large Nipah outbreaks beyond Bangladesh: Preventing a tragedy like Ebola in West Africa.
    Donaldson H; Lucey D
    Int J Infect Dis; 2018 Jul; 72():69-72. PubMed ID: 29879523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of ebola virus disease.
    Kilgore PE; Grabenstein JD; Salim AM; Rybak M
    Pharmacotherapy; 2015 Jan; 35(1):43-53. PubMed ID: 25630412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral effect of ranpirnase against Ebola virus.
    Hodge T; Draper K; Brasel T; Freiberg A; Squiquera L; Sidransky D; Sulley J; Taxman DJ
    Antiviral Res; 2016 Aug; 132():210-8. PubMed ID: 27350309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain.
    Marzi A; Feldmann F; Hanley PW; Scott DP; Günther S; Feldmann H
    Emerg Infect Dis; 2015 Oct; 21(10):1777-83. PubMed ID: 26402165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.